While Rb-deficiency (usually by way of an inactivating mutation) has been thought to be rare in meningiomas, increased CDKN2A mRNA expression may act as a transcriptomic signature for this alteration [10, 21, 45]. This evidence concerns the gene RB1 and hyperinsulinemic hypoglycemia, familial, 4.